Research participants needed
Why is this study being done?
To help us evaluate which treatment works best to reduce or reverse visual loss in people with IIH
The study team will follow participants randomized to one of three treatment groups:
- Medical Therapy (MT)
- Optic Nerve Sheath Fenestration plus MT
- Sterotactic Ventriculo-Perotoneal CSF Shunting plus MT
Please call prior to performing a lumbar puncture
Who? Participant must be 18-64 years old with idiopathic intracranial hypertension (IIH) and moderate to severe visual loss.
How long will it take? Participants will be in the randomized trial for 6 months and will be followed for up to 3 years.